Evidence map›Paper›PMID 27001854›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

Club cells surviving influenza A virus infection induce temporary nonspecific antiviral immunity.

Jennifer R Hamilton, David Sachs, Jean K Lim, Ryan A Langlois, Peter Palese, Nicholas S Heaton

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 58 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. The role of virus in nasal inflammation.European journal of medical research · 2025
    Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Viral Respiratory Pathogens and Lung Injury.Clinical microbiology reviews · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Jennifer R HamiltonDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029;
David SachsDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 10029;
Jean K LimDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029;
Ryan A LangloisDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029; Department of Microbiology and Immunology, University of Minnesota Medical School, Minneapolis, MN 55455;
Peter PaleseDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029;
Nicholas S HeatonDepartment of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029; Department of Molecular Genetics and Microbiology, Duke University, Durham, NC 27710 nicholas.heaton@duke.edu.
Icahn School of Medicine at Mount Sinai · USUniversity of Minnesota Medical Center · US

Funding

Understanding Human B Cell Responses to Influenza to Improve the Influenza U19AI109946 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI RAVETCH, JEFFREY VICTOR · 2014 to 2018
$9.6M
Chemokine regulation of myeloid cell populations during West Nile virus infectionR01AI108715 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI LIM, JEAN KYOU · 2014 to 2017
$1.4M
Survival of influenza A virus infected cells and effects on pathogenesisK22AI116509 · NIAID · DUKE UNIVERSITY · PI HEATON, NICHOLAS S · 2016 to 2017
$267k
Novel cellular pathways that allow cells to survive influenza A virus infectionF31AI120648 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI HAMILTON, JENNIFER R · 2016 to 2018
$97k
NIAID NIH HHS F31 AI120648NIAID NIH HHS HHSN272201400008CNIAID NIH HHS K22 AI116509NIAID NIH HHS R01 AI108715NIAID NIH HHS U19 AI109946
6 · The paper itself

Abstract

A brief window of antigen-nonspecific protection has been observed after influenza A virus (IAV) infection. Although this temporary immunity has been assumed to be the result of residual nonspecific inflammation, this period of induced immunity has not been fully studied. Because IAV has long been characterized as a cytopathic virus (based on its ability to rapidly lyse most cell types in culture), it has been a forgone conclusion that directly infected cells could not be contributing to this effect. Using a Cre recombinase-expressing IAV, we have previously shown that club cells can survive direct viral infection. We show here not only that these cells can eliminate all traces of the virus and survive but also that they acquire a heightened antiviral response phenotype after surviving. Moreover, we experimentally demonstrate temporary nonspecific viral immunity after IAV infection and show that surviving cells are required for this phenotype. This work characterizes a virally induced modulation of the innate immune response that may represent a new mechanism to prevent viral diseases.

Indexed as

AnimalsCell LineCross ProtectionCytokinesDogsHEK293 CellsHost-Pathogen InteractionsHumansImmunity, InnateInfluenza A Virus, H1N1 SubtypeInfluenza, HumanLungMadin Darby Canine Kidney CellsMiceMice, Inbred C57BLOrthomyxoviridae InfectionsCytokinesalternative cell fateantiviral immunityinfluenza virusRNA sequencing

Identifiers

PMID27001854
PMCPMC4833272
OpenAlexW2326079572

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.